Heron Therapeutics clinical trials
Also known as A.P. Pharma, AP Pharma.
The registry lists 26 studies whose lead sponsor is Heron Therapeutics. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 13, 2026.
Our grouping of 1 registry name, not the registry’s. See them and correct one ↓
- 26studies on the registry
- 0open to participants now
What it is testing
The drugs Heron Therapeutics’ studies test, most studies first; none is open now — 7 drugs with a page of their own. Each count opens the studies in search.
Studies, none open
What changed recently
From the registry's own updates since Oct 19, 2026.
Results posted4
- Bupivacaine HCl PK and Safety in Augmentation MammoplastyOct 28, 2026NCT03705065
- Cohort 2 (Abdominoplasty) of: A Multi-surgery Assessment of ZYNRELEF (HTX-011)Oct 28, 2026NCT06109428
- PK and Safety After C-SectionOct 27, 2026NCT03955211
- Cohort 1 (TSA) of: A Multi-surgery Assessment of ZYNRELEF (HTX-011)Oct 27, 2026NCT06109415
All 26 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 11
- 12
- 13
- 14
- 15
- 16
- 417
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started; 1 started before 2011. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Heron Therapeutics.
- Heron Therapeutics26 studiesSame company
Something wrong?
Focus areas
Conditions Heron Therapeutics leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 26 of 26.
- PK and Safety After C-SectionCompletedNCT03955211Phase 2
- Bupivacaine HCl PK and Safety in Augmentation MammoplastyCompletedNCT03705065Phase 4
- Cohort 2 (Abdominoplasty) of: A Multi-surgery Assessment of ZYNRELEF (HTX-011)CompletedNCT06109428Phase 4
- Cohort 1 (TSA) of: A Multi-surgery Assessment of ZYNRELEF (HTX-011)CompletedNCT06109415Phase 4
- HTX-011 for Post-bunionectomy AnalgesiaCompletedNCT02471898Phase 2
- Dose-Escalation Study of HTX-034 Following BunionectomyCompletedNCT04398329Phase 1/2
- Study of Post-Herniorrhaphy Non-opioid MMA RegimensCompletedNCT03907176Phase 3
- Pediatric Postoperative Analgesia Herniorrhaphy StudyWithdrawnNCT03922048Phase 2
- Pilot Herniorrhaphy Study for Postoperative AnalgesiaCompletedNCT02504580Phase 2
- APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for CancerCompletedNCT00343460Phase 3
- A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HECCompletedNCT02106494Phase 3
- Phase 2 Herniorrhaphy Study for Opioid EliminationCompletedNCT03695367Phase 2
- Evaluation of the Efficacy and Safety of HTX-011 for Postoperative Analgesia Following Abdominoplasty SurgeryCompletedNCT02689258Phase 2
- Phase 2 Bunionectomy HTX-011 Administration StudyCompletedNCT03718039Phase 2
- Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)CompletedNCT03237481Phase 3
- Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1)TerminatedNCT04470622Phase 2
- Bunionectomy Study for Postoperative Analgesia (EPOCH 1)CompletedNCT03295721Phase 3
- Total Knee Arthroplasty Infiltration Study for Postoperative AnalgesiaCompletedNCT03015532Phase 2
- Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) RegimenCompletedNCT03974932Phase 3
- Phase 2B Upper Extremity Nerve Block StudyCompletedNCT03011333Phase 2
- Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following BunionectomyCompletedNCT02762929Phase 2
- A Phase I Study of the Effects of APF530 Exposure, Granisetron and MoxifloxacinCompletedNCT01416259
- A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. Master Protocol HTX-011-401.Active, not recruitingNCT05109312Phase 4
- Safety Study of Repeat Doses of SUSTOL in AdultsActive, not recruitingNCT05434663Phase 4
- HTX-011 in Spinal SurgeryCompletedNCT04911062Phase 2
- Extended Delivery of Bupivacaine Study in HerniorrhaphyCompletedNCT04102267Phase 4